Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
about
Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-CancerLinking Genes to Cardiovascular Diseases: Gene Action and Gene-Environment Interactions.Identification of a novel hypertrophic cardiomyopathy-associated mutation using targeted next-generation sequencing.Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeq™ panelNext-generation sequencing of human opioid receptor genes based on a custom AmpliSeq™ library and ion torrent personal genome machineDevelopment of a Comprehensive Sequencing Assay for Inherited Cardiac Condition GenesIdentification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses.Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.Multiplex PCR Targeted Amplicon Sequencing (MTA-Seq): Simple, Flexible, and Versatile SNP Genotyping by Highly Multiplexed PCR Amplicon Sequencing.Identification of Novel Candidate Markers of Type 2 Diabetes and Obesity in Russia by Exome Sequencing with a Limited Sample Size
P2860
Q26771116-E02F5B43-3E67-4E7F-8065-F9D4AE0841E0Q28602218-E075CD8D-FFC4-4522-B82E-AA9CE83DF699Q33783935-F5DDA3E2-3C56-4BDD-89AC-365DBB966BD2Q33848528-8C86A9C9-B816-436E-879F-0CBC005CE0D3Q36159969-078239EA-C41C-4AB6-8044-7FC4B06F4F41Q36620496-B4D3A36A-16E5-4A0A-A47E-3B4014894EBFQ36903712-A68AC28F-41AF-4F98-9196-FF96535B7C2DQ39800417-861DF583-1770-488B-AD16-76E1F31C73D3Q41237982-0FD9BE37-67C3-4C5D-8022-14B44FBAF0BAQ55279297-4BA00976-824B-445E-835B-37832BC3BF2BQ58768285-936F8AF0-FF05-4B34-ABE2-E43B11592E4E
P2860
Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted next-generation seque ...... d a cardiomyopathy risk group.
@ast
Targeted next-generation seque ...... d a cardiomyopathy risk group.
@en
type
label
Targeted next-generation seque ...... d a cardiomyopathy risk group.
@ast
Targeted next-generation seque ...... d a cardiomyopathy risk group.
@en
prefLabel
Targeted next-generation seque ...... d a cardiomyopathy risk group.
@ast
Targeted next-generation seque ...... d a cardiomyopathy risk group.
@en
P2093
P50
P1433
P1476
Targeted next-generation seque ...... nd a cardiomyopathy risk group
@en
P2093
Andrey M Sarana
Andrey S Glotov
Anton V Alexandrov
Elena A Kurnikova
Elena A Zhukova
Irina V Poliakova
Natalia N Chakova
Oleg S Glotov
Sergey G Sherbak
Sergey V Kazakov
P304
P356
10.1016/J.CCA.2015.04.014
P577
2015-04-17T00:00:00Z